Agarwal Vineet 4
4 · Korro Bio, Inc. · Filed Nov 12, 2024
Insider Transaction Report
Form 4
Korro Bio, Inc.KRRO
Agarwal Vineet
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-11-11−800→ 30,807 totalExercise: $11.68Exp: 2031-05-29→ Common Stock (800 underlying) - Sale
Common Stock
2024-11-11$70.00/sh−800$56,000→ 0 total - Exercise/Conversion
Common Stock
2024-11-11$11.68/sh+800$9,344→ 800 total
Footnotes (2)
- [F1]The reported transactions occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 19, 2024.
- [F2]The shares subject to the option vest as to 25% of the shares on May 11, 2022, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.